Skip to Main Content

Paper Details

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.
Eur J Hum Genet
96
2011
CDKN2A, CDKN2A mutation, CDKN2A mutations, Lymphocyte, melanoma, p14ARF, p16INK4, pancreatic, pancreatic adenocarcinoma, pancreatic cancer, patients

Datasets

Release 1.2